Venrock Healthcare Capital Partners III, L.P. - Significant Ownership

Signature - Title
/s/ Sherman G. Souther - By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Venrock Healthcare Capital Partners III, L.P..

Significant Ownership of Venrock Healthcare Capital Partners III, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORKA ORUKA THERAPEUTICS, INC. Common Stock, par value $0.001 per share 11.1% $39.1M 4.15M Venrock Healthcare Capital Partners III, L.P. Feb 10, 2025
ENGN enGene Holdings Inc. Common Shares 9.9% $20.2M 5.05M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 9.9% $12.9M -$1.38M 6.35M -9.64% Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 9.9% $10.2M 873K Venrock Healthcare Capital Partners III, L.P. Mar 26, 2025
Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 9.9% 1.39M Venrock Healthcare Capital Partners III, L.P. Jun 13, 2025
JADE BIOSCIENCES, INC. Common Stock, $0.0001 par value 9.9% 3.22M Venrock Healthcare Capital Partners III, L.P. Apr 28, 2025
Vor Biopharma Inc. Common Stock, $0.0001 par value per share 9.9% 761K Venrock Healthcare Capital Partners III, L.P. Sep 18, 2025
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 8.2% $9.22M 13M Venrock Healthcare Capital Partners III, L.P. May 13, 2025
ORIC ORIC Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 7.7% $35M $18.1M 6.6M +107% Venrock Healthcare Capital Partners III, L.P. Apr 8, 2025
SVRA Savara Inc. Common Stock, par value $0.001 per share 5.2% $26.8M 9.02M Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 4.9% $29.1M -$4.97M 1.02M -14.6% Venrock Healthcare Capital Partners III, L.P. Mar 31, 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.7% $1.9M 3.96M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $32.8M 2.69M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 4.5% $42.2M 3.58M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
ATXS Astria Therapeutics, Inc. Common Stock, $0.001 par value per share 4.4% $10M 2.46M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
APLT Applied Therapeutics, Inc. Common Stock $0.0001 par value per share 4.1% $1.78M -$2M 5.57M -52.8% Venrock Healthcare Capital Partners III, L.P. Mar 31, 2025
PHVS Pharvaris N.V. Ordinary shares, par value EURO0.12 per share 3.8% $46.8M 2.05M Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
CDTX CIDARA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 3.2% $42.8M -$30.8M 639K -41.8% Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
DNTH Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share 3.1% $24.8M 1M Venrock Healthcare Capital Partners III, L.P. Jun 30, 2025
AQST Aquestive Therapeutics, Inc. Common stock, $0.001 par value per share 2.9% $6.23M 2.63M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
MRSN MERSANA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 2.9% $1.07M -$2.01M 3.57M -65.2% Venrock Healthcare Capital Partners III, L.P. Mar 31, 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 1.5% $1.8M -$6.03M 678K -77% Venrock Healthcare Capital Partners III, L.P. Mar 31, 2025
ADVM ADVERUM BIOTECHNOLOGIES, INC. Common Stock, $0.0001 par value 0% $0 0 Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024

Schedules 13D/G Reported by Venrock Healthcare Capital Partners III, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.